111 related articles for article (PubMed ID: 22688102)
1. [A case of advanced primary colorectal carcinoma accompanied by liver metastasis in which ileus developed due to marked fibrosis with cicatricial formation in primary colorectal cancer treated by chemotherapy including bevacizumab].
Takanashi K; Katsuki S; Fujita T; Waga E; Shimodate Y; Sasaki K; Someya T; Ohno K; Fujita M
Nihon Shokakibyo Gakkai Zasshi; 2012 May; 109(5):766-73. PubMed ID: 22688102
[TBL] [Abstract][Full Text] [Related]
2. Pathologic complete response to neoadjuvant FOLFOX in combination with bevacizumab in unresectable metastatic colorectal carcinoma.
Duffy A; Shia J; Huitzil-Melendez FD; Fong Y; O'Reilly EM
Clin Colorectal Cancer; 2008 Mar; 7(2):140-3. PubMed ID: 18501074
[TBL] [Abstract][Full Text] [Related]
3. Unusual ischemic complication of bevacizumab treatment for metastatic colorectal carcinoma.
Ryan EM; Hanly A; Morrin MM; McNamara DA
J Clin Oncol; 2013 Oct; 31(30):e433-4. PubMed ID: 23775957
[No Abstract] [Full Text] [Related]
4. [Bevacizumab in the treatment of colorectal carcinoma: news from ASCO 2008].
Mansueto G; Longo F
Tumori; 2008; 94(4):suppl 1-14. PubMed ID: 18822711
[No Abstract] [Full Text] [Related]
5. First description of an uterine perforation potentially imputable to treatment with bevacizumab.
Uguen T; Leconte B; Desgrippes R; Tchoundeu B; Bretagne JF; Manfredi S
Acta Oncol; 2012 Nov; 51(8):1102-4. PubMed ID: 23020310
[No Abstract] [Full Text] [Related]
6. [A case of pathologically complete response in a patient with locally advanced sigmoid colon cancer after chemotherapy including bevacizumab/FOLFOX4].
Mikami Y; Tamura N; Akiyama M; Muraoka T; Sakurai U; Sawabe M
Gan To Kagaku Ryoho; 2014 Jun; 41(6):777-9. PubMed ID: 25129094
[TBL] [Abstract][Full Text] [Related]
7. Extensive bowel necrosis related to bevacizumab in metastatic rectal cancer patient: a case report and review of literature.
Takada S; Hoshino Y; Ito H; Masugi Y; Terauchi T; Endo K; Kimata M; Furukawa J; Shinozaki H; Kobayashi K; Ogata Y
Jpn J Clin Oncol; 2015 Mar; 45(3):286-90. PubMed ID: 25489005
[TBL] [Abstract][Full Text] [Related]
8. Axitinib or bevacizumab plus FOLFIRI or modified FOLFOX-6 after failure of first-line therapy for metastatic colorectal cancer: a randomized phase II study.
Bendell JC; Tournigand C; Swieboda-Sadlej A; Barone C; Wainberg ZA; Kim JG; Pericay C; Pastorelli D; Tarazi J; Rosbrook B; Bloom J; Ricart AD; Kim S; Sobrero AF
Clin Colorectal Cancer; 2013 Dec; 12(4):239-47. PubMed ID: 24188685
[TBL] [Abstract][Full Text] [Related]
9. [Incidence and management of adverse events in FOLFOX plus bevacizumab therapy for colorectal cancer].
Shimodaira H
Nihon Rinsho; 2015 Feb; 73 Suppl 2():582-6. PubMed ID: 25831827
[No Abstract] [Full Text] [Related]
10. Onset of segmental colitis associated with diverticulosis after treatment with bevacizumab for metastatic colorectal carcinoma.
Tursi A
J Crohns Colitis; 2012 Aug; 6(7):809-10. PubMed ID: 22658805
[No Abstract] [Full Text] [Related]
11. Randomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasis.
Martin RC; Scoggins CR; Schreeder M; Rilling WS; Laing CJ; Tatum CM; Kelly LR; Garcia-Monaco RD; Sharma VR; Crocenzi TS; Strasberg SM
Cancer; 2015 Oct; 121(20):3649-58. PubMed ID: 26149602
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of targeted therapy with cetuximab in patients with K-ras wild-type colorectal cancer presenting with initially unresectable metastases limited to the liver in a German setting.
Asseburg C; Frank M; Köhne CH; Hartmann JT; Griebsch I; Mohr A; Osowski U; Schulten J; Mittendorf T
Clin Ther; 2011 Apr; 33(4):482-97. PubMed ID: 21635994
[TBL] [Abstract][Full Text] [Related]
13. [Pathologically complete response of multiple liver metastases from rectal cancer treated with mFOLFOX6 plus bevacizumab].
Inoue M; Uehara K; Ishiguro S; Nishio H; Ebata T; Yokoyama Y; Kokuryo T; Tsunoda N; Igami T; Sugawara G; Fukaya M; Nagino M
Nihon Shokakibyo Gakkai Zasshi; 2010 May; 107(5):760-7. PubMed ID: 20460850
[TBL] [Abstract][Full Text] [Related]
14. FOLFOX plus cetuximab for a patient with metastatic colorectal cancer with icterus due to multiple liver metastases.
Mizota A; Shitara K; Kondo C; Nomura M; Yokota T; Takahari D; Ura T; Muro K
Gan To Kagaku Ryoho; 2011 Jul; 38(7):1205-8. PubMed ID: 21772113
[TBL] [Abstract][Full Text] [Related]
15. A rare hematological adverse event induced by bevacizumab: severe thrombocytopenia.
Dior M; Coriat R; Mir O; Brezault C; Perkins G; Dhooge M; Goldwasser F; Chaussade S
Am J Med; 2012 Aug; 125(8):828-30. PubMed ID: 22840668
[TBL] [Abstract][Full Text] [Related]
16. [A case of metastatic colorectal cancer with icterus due to multiple liver metastases treated effectively by FOLFOX plus bevacizumab].
Terasawa T; Koja S; Yasuda K; Fukuda K
Gan To Kagaku Ryoho; 2013 Aug; 40(8):1115-8. PubMed ID: 23986063
[TBL] [Abstract][Full Text] [Related]
17. A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme).
Avallone A; Piccirillo MC; Aloj L; Nasti G; Delrio P; Izzo F; Di Gennaro E; Tatangelo F; Granata V; Cavalcanti E; Maiolino P; Bianco F; Aprea P; De Bellis M; Pecori B; Rosati G; Carlomagno C; Bertolini A; Gallo C; Romano C; Leone A; Caracò C; de Lutio di Castelguidone E; Daniele G; Catalano O; Botti G; Petrillo A; Romano GM; Iaffaioli VR; Lastoria S; Perrone F; Budillon A
BMC Cancer; 2016 Feb; 16():69. PubMed ID: 26857924
[TBL] [Abstract][Full Text] [Related]
18. Correlation between response to chemotherapy with concomitant bevacizumab for hepatic metastasis of colorectal cancer and degree of enhancement using contrast-enhanced computed tomography.
Osawa G; Yoshimatsu K; Yokomizo H; Okayama S; Sagawa M; Naritaka Y
Cancer Chemother Pharmacol; 2013 Jul; 72(1):209-15. PubMed ID: 23670642
[TBL] [Abstract][Full Text] [Related]
19. Oncologic emergencies secondary to advanced colorectal cancer successfully treated with oxaliplatin/5-fluorouracil/leucovorin: report of three cases.
Cavanna L; Bertè R; Bidin L; Civardi G; Anselmi E; Lazzaro A; Moroni CF; Palladino MA; Rodinò C; Vallisa D
J Chemother; 2005 Jun; 17(3):334-8. PubMed ID: 16038529
[TBL] [Abstract][Full Text] [Related]
20. [A case of severe bevacizumab-induced ischemic pancolitis, treated with conservative management].
Lee HN; Lee MA; Kim SW; Lim Y; Lee H; Lee HM; Won HS; Chun SH
Korean J Gastroenterol; 2011 Jul; 58(1):42-6. PubMed ID: 21778803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
